Tokyo, Japan

Keijiro Odo

This inventor holds 1 USPTO granted patent. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keijiro Odo. Retrieved from https://idiyas.com/inventor/keijiro-odo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keijiro Odo: Innovator in Pharmaceutical Chemistry

Introduction

Keijiro Odo is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes. His work has led to advancements in the production of important chemical compounds.

Latest Patents

One of Keijiro Odo's key patents is titled "Process for producing 2-aminomethyl-1-ethylpyrrolidine." This patent describes a method for producing 2-aminomethyl-1-ethylpyrrolidine by the electrolytic reduction of 1-ethyl-2-nitromethylenepyrrolidine. This process showcases his expertise in chemical synthesis and innovation.

Career Highlights

Keijiro Odo is associated with Yamanouchi Pharmaceutical Company Ltd., where he has contributed to various research and development projects. His work has been instrumental in enhancing the company's portfolio of pharmaceutical products. He holds 1 patent, reflecting his commitment to innovation in the industry.

Collaborations

Throughout his career, Keijiro Odo has collaborated with esteemed colleagues such as Eiichi Ichikawa and Kazuharu Tamazawa. These collaborations have fostered a productive environment for research and development, leading to significant advancements in their field.

Conclusion

Keijiro Odo's contributions to pharmaceutical chemistry and his innovative processes have made a lasting impact on the industry. His work continues to inspire future advancements in chemical synthesis and pharmaceutical development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…